Supreme Court asks Baba Ramdev, Acharya Balkrishna to appear before it for not replying to contempt notice.
Supreme Court summons Patanjali's Balkrishna and Ramdev regarding misleading advertisements. The contempt notice was ignored. Concern over herbal product claims.
The Supreme Court has summoned Acharya Balkrishna, the managing director of Patanjali Ayurveda, along with yoga guru Baba Ramdev to appear in the next hearing regarding the case of misleading advertisements. This decision came after the company failed to respond to a contempt notice. Additionally, Baba Ramdev has been served notice to justify why contempt proceedings should not be initiated against him. In February, the court strongly criticized the dissemination of herbal product advertisements claiming to cure diseases, stating that the entire nation had been deceived.
Earlier, the court had issued a notice to Patanjali Ayurved and its managing director, questioning why contempt proceedings should not be launched against them for apparently breaching the company's commitment made in court regarding their product advertising and medicinal claims.
Furthermore, the court had instructed the company and its officials to refrain from making public statements against any medical systems. The court sought information from the government regarding actions taken against Patanjali Ayurveda for alleged false claims and misrepresentations in its advertisements asserting the curative properties of its medicines. The Indian Medical Association (IMA) had filed a petition against the company, accusing it of conducting a smear campaign against modern medicine.
On November 21 of the previous year, the company had assured the court that it would adhere to all laws, particularly those concerning product advertising and branding, and would refrain from making casual statements about medicinal effectiveness or disparaging any medical system in the media. This commitment followed the court's warning to the company against making false and misleading claims in its advertisements. Last month, the court barred Patanjali Ayurved from advertising or branding products intended to treat ailments categorized as diseases, disorders, or conditions under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Follow the Hindeez on Google News
Follow the Hindeez channel on WhatsApp
We hate spam as much as you do
© Hindeez 2024, All Rights Reserved
